BMRN Shariah Compliance
Screening Methodology: AAOIFI
UNLOCK FOR FREE
Last Updated: February 28, 2026
Report Source: 2025 Annual Report
BioMarin Pharmaceutical Inc. Stock Analysis BMRN
United States Health Care Large Cap Report: BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. The company is headquartered in San Rafael California, California and currently employs 3,040 full-time employees. The firm has eight commercial therapies and a clinical and preclinical pipeline. Its commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno-associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Its key clinical programs include Vosoritide, BMN 333, BMN 390, BMN 351, BMN 349, and INZ-701. Its late-stage enzyme replacement therapy, INZ-701, is being developed for the treatment of ENPP1 deficiency.
Read More BioMarin Pharmaceutical Inc (BMRN) Chart
BioMarin Pharmaceutical Inc (BMRN) vs CBOE Volatility Index (VIX) Comparative Returns
Analysis of BioMarin Pharmaceutical Inc (BMRN) stock performance compared to the broader market (CBOE Volatility Index (VIX)) across multiple timeframes.
YTD Performance
- BioMarin Pharma... (BMR...) -1.55%
- CBOE Volatility Index (VIX) 7.42%
BioMarin Pharma... Underperformed CBOE Volatility Index (VIX) by 8.97%
1Y Performance
- BioMarin Pharma... (BMR...) -17.12%
- CBOE Volatility Index (VIX) -3.02%
BioMarin Pharma... Underperformed CBOE Volatility Index (VIX) by 14.10%
3Y Performance
- BioMarin Pharma... (BMR...) -35.17%
- CBOE Volatility Index (VIX) -19.46%
BioMarin Pharma... Underperformed CBOE Volatility Index (VIX) by 15.71%
5Y Performance
- BioMarin Pharma... (BMR...) -23.79%
- CBOE Volatility Index (VIX) -51.47%
BioMarin Pharma... Outperformed CBOE Volatility Index (VIX) by 27.68%
Key Statistics of BioMarin Pharmaceutical Inc (BMRN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$56.71Volume
2.47MP/E Ratio (TTM)
31.6652 Week Range
Market Cap
10.86BAvg. Volume
2.24MDividend Yield
-Financial Metrics & Statements of BioMarin Pharmaceutical Inc (BMRN)
Super Investors Invested in BioMarin Pharmaceutical Inc (BMRN)
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Dodge & Cox
% Portfolio:
0.60 Recent Activity:1.42%
Joel Greenblatt
% Portfolio:
0.06 Recent Activity:122.14%
Jefferies Group
% Portfolio:
<0.01 Recent Activity:100.00%
Mario Gabelli
% Portfolio:
<0.01 Recent Activity:-17.43%
Community-Curated Collections with BioMarin Pharmaceutical Inc (BMRN) ( With BMRN )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's for BioMarin Pharmaceutical Inc (BMRN)
- According to Musaffa’s Shariah screening methodology, BioMarin Pharmaceutical Inc (BMRN) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
Related Halal Stocks to BioMarin Pharmaceutical Inc (BMRN)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
